Samantha McLemore’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142M Sell
709,587
-1,528
-0.2% -$314K 4.65% 6
2026
Q1
$124M Buy
711,115
+72,301
+11% +$13.3M 4.53% 6
2025
Q4
$119M Buy
638,814
+6,130
+1% +$1.14M 4.6% 7
2025
Q3
$118M Sell
632,684
-1,489
-0.2% -$260K 4.73% 6
2025
Q2
$100M Buy
634,173
+7,221
+1% +$909K 4.52% 7
2025
Q1
$67.9M Buy
626,952
+18,389
+3% +$2.33M 3.49% 13
2024
Q4
$81.7M Sell
608,563
-165
-0% -$22.7K 3.77% 8
2024
Q3
$73.9M Buy
608,728
+2,889
+0.5% +$341K 3.63% 9
2024
Q2
$74.8M Sell
605,839
-221
-0% -$22.3K 3.98% 9
2024
Q1
$54.8M Buy
+606,060
New +$43.9M 2.67% 15

Other funds holding NVDA

Samantha McLemore's NVDA Position: Q2 2026 in Review

Samantha McLemore reduced its NVIDIA (NVDA) stake by 0.21% in Q2 2026, selling an estimated $314K and leaving 709,587 shares worth $142M. The position accounts for 4.65% of the portfolio, ranked #6.

Samantha McLemore first reported a position in NVDA in Q1 2024 and has held it in 10 quarters since. 5,937 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

  • Samantha McLemore held 709,587 shares of NVIDIA worth $142M as of Q2 2026.
  • Samantha McLemore sold 1,528 NVIDIA shares in Q2 2026, an estimated $314K.
  • NVIDIA made up 4.65% of Samantha McLemore's portfolio in Q2 2026, its #6 holding.
  • Samantha McLemore first reported a position in NVIDIA in Q1 2024 and has held it in 10 quarters since.
  • 5,937 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.